NCT00241020View on ClinicalTrials.gov

Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma

PHASE3CompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Advanced Hepatocellular Carcinoma
Interventions
DRUG

Octreotide

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY